UPLC–QTOF/MS-based metabolomic profiling of Lespedeza species for marker selection and monoamine oxidase inhibitory activity

Abstract Monoamine oxidases (MAO)-A and MAO-B are key enzymes involved in the regulation of monoamine neurotransmitters and are closely associated with various neuropsychiatric and neurodegenerative disorders. In this study, the MAO-A and MAO-B inhibitory activities of methanol extracts from Korean native Lespedeza species were compared and related to metabolite profiles using ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC–QTOF/MS)-based metabolomics combined with in silico prediction of central nervous system distribution. Among the tested species ( L. maximowiczii , L. thunbergii , L. tomentosa , and L. cyrtobotrya ), L. cyrtobotrya exhibited the strongest inhibitory activity, with the stem extract showing the most pronounced effect (MAO-A 80.33% and MAO-B 91.91% inhibition at 20 µg/mL). Untargeted metabolomic analysis tentatively identified 65 secondary metabolites, and multivariate statistical analyses including principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) clearly discriminated L. cyrtobotrya from the other species and further separated its leaf and stem extracts. Marker selection based on the OPLS-DA S-plot and subsequent box plot analysis ( p < 0.05) indicated that non-prenylated flavonoids were enriched in the leaf, whereas prenylated flavonoids such as diplacone, sanggenol A, and xanthoangelol were relatively enriched in the stem. SwissADME and pkCSM-based in silico predictions indicated diverse physicochemical and central nervous system distribution properties among the selected metabolites (log P − 0.24–5.30; log BB − 2.41–−0.57; log PS − 5.24–−1.95), with stem-enriched prenylated flavonoids showing relatively higher lipophilicity. Overall, this integrated bioactivity-metabolomics approach identifies L. cyrtobotrya stem as a promising source of MAO-modulating metabolites, including diplacone and sanggenol A, whose moderate MAO inhibitory activities were directly confirmed in the present study.

Authors

Institutions

Publication Details

Journal
Applied Biological Chemistry
Published
2026-11-16
DOI
https://doi.org/10.1186/s13765-026-01152-8
Primary Topic
Phytochemistry and Biological Activities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

UPLC–QTOF/MS-based metabolomic profiling of Lespedeza species for marker selection and monoamine oxidase inhibitory activity

Hyung Won Ryu, Sei‐Ryang Oh, Sung‐Kyun Ko, Hyoung‐Geun Kim et al.
1 links
Applied Biological Chemistry
Phytochemistry and Biological Activities
article

UPLC–QTOF/MS-based metabolomic profiling of Lespedeza species for marker selection and monoamine oxidase inhibitory activity

Hyung Won Ryu, Sei‐Ryang Oh, Sung‐Kyun Ko, Hyoung‐Geun Kim, Dongho Lee, Su‐Yeon Lee, Su-Ah Lee, Doo-Young Kim, Jung-Hee Kim, Ji-Hong Kim
article en

Abstract

Abstract Monoamine oxidases (MAO)-A and MAO-B are key enzymes involved in the regulation of monoamine neurotransmitters and are closely associated with various neuropsychiatric and neurodegenerative disorders. In this study, the MAO-A and MAO-B inhibitory activities of methanol extracts from Korean native Lespedeza species were compared and related to metabolite profiles using ultra-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UPLC–QTOF/MS)-based metabolomics combined with in silico prediction of central nervous system distribution. Among the tested species ( L. maximowiczii , L. thunbergii , L. tomentosa , and L. cyrtobotrya ), L. cyrtobotrya exhibited the strongest inhibitory activity, with the stem extract showing the most pronounced effect (MAO-A 80.33% and MAO-B 91.91% inhibition at 20 µg/mL). Untargeted metabolomic analysis tentatively identified 65 secondary metabolites, and multivariate statistical analyses including principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) clearly discriminated L. cyrtobotrya from the other species and further separated its leaf and stem extracts. Marker selection based on the OPLS-DA S-plot and subsequent box plot analysis ( p < 0.05) indicated that non-prenylated flavonoids were enriched in the leaf, whereas prenylated flavonoids such as diplacone, sanggenol A, and xanthoangelol were relatively enriched in the stem. SwissADME and pkCSM-based in silico predictions indicated diverse physicochemical and central nervous system distribution properties among the selected metabolites (log P − 0.24–5.30; log BB − 2.41–−0.57; log PS − 5.24–−1.95), with stem-enriched prenylated flavonoids showing relatively higher lipophilicity. Overall, this integrated bioactivity-metabolomics approach identifies L. cyrtobotrya stem as a promising source of MAO-modulating metabolites, including diplacone and sanggenol A, whose moderate MAO inhibitory activities were directly confirmed in the present study.

Applied Biological ChemistryVol. 69(1)
Korea University (KR), Korea Research Institute of Bioscience and Biotechnology (KR), Korea University of Science and Technology (KR)
Good health and well-being
Phytochemistry and Biological Activities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon